Post by Gilead Sciences
837,608 followers
Innovation in the treatment landscape is critical for those living with metastatic triple-negative breast cancer (mTNBC), the most aggressive, fast-growing subtypes of breast cancer. Hear from patients and advocates on the reality behind living with mTNBC.
Video Content